Carnitine Deficiency

What Is Carnitine Deficiency?

Carnitine is a small amino-acid-derived molecule whose main job is to carry long-chain fatty acids across the inner mitochondrial membrane so they can be burned for energy. Without it, fat arrives at the door of the mitochondrion and cannot get in. Tissues that lean heavily on fat as fuel — heart muscle, skeletal muscle, and the liver during fasting — are the first to feel the shortfall. Carnitine also helps clear accumulated acyl groups out of the mitochondrion as acylcarnitines, which is a second, quieter role that matters a great deal in certain metabolic diseases.

Carnitine is called conditionally essential. Healthy adults make roughly a quarter of their daily supply in liver and kidney from the amino acids lysine and methionine, using vitamin C, vitamin B6, niacin and iron as cofactors; the rest comes from food, overwhelmingly red meat and dairy. Because the kidney reabsorbs carnitine very efficiently, most people — including long-term vegetarians and vegans, who typically show lower but still adequate blood levels — never become deficient. True deficiency is a medical event with a cause behind it, not a lifestyle drift.

Primary Versus Secondary Deficiency

The distinction is the single most important idea in this topic.

• Primary carnitine deficiency (systemic carnitine deficiency) is an inherited disorder of the OCTN2 carnitine transporter, encoded by the SLC22A5 gene. Cells cannot take carnitine up and the kidney cannot reabsorb it, so carnitine pours into the urine and plasma levels fall very low. It is autosomal recessive, usually presents in infancy or early childhood with cardiomyopathy, muscle weakness or hypoketotic hypoglycaemia during illness, and is picked up in many countries by newborn screening. It requires lifelong prescription levocarnitine under a metabolic specialist.
• Secondary carnitine deficiency is acquired. It results from renal loss (haemodialysis, Fanconi syndrome), drug interactions (valproate, pivalate-conjugated antibiotics, some antiretrovirals, cisplatin), reduced synthesis or intake (cirrhosis, severe malnutrition, preterm infants on carnitine-free parenteral nutrition, short bowel syndrome), or from other fatty-acid oxidation and organic acid disorders in which carnitine is consumed mopping up toxic acyl groups.

The management, prognosis and urgency of these two situations are different, and lumping them together is the commonest error in popular writing on the subject.

What Are the Signs and Symptoms of Carnitine Deficiency?

Symptoms track the tissues that depend most on fat oxidation, and they characteristically worsen with fasting, infection, prolonged exercise or any other metabolic stress.

Muscle and Energy

• Marked exercise intolerance — fatigue out of proportion to effort, especially in sustained or endurance activity
• Proximal muscle weakness (hips, shoulders, neck), sometimes a waddling gait in children
• Muscle pain, cramping, or episodes of dark cola-coloured urine from rhabdomyolysis
• Poor exercise recovery and unusual post-exertional exhaustion

Heart

• Dilated or hypertrophic cardiomyopathy — often the presenting sign of primary deficiency in a toddler
• Breathlessness on exertion or lying flat, poor feeding in infants, swelling of ankles
• Arrhythmias; in untreated primary deficiency, sudden cardiac events have been described

Liver and Metabolic

• Hypoketotic hypoglycaemia — low blood sugar during a fast or a viral illness without the expected rise in ketones
• Lethargy, irritability, vomiting or altered consciousness during an intercurrent illness (a metabolic crisis)
• Enlarged liver, fatty liver, raised ammonia and liver enzymes during episodes

In Infants and Children

• Poor feeding and failure to thrive
• Floppiness (hypotonia) and delayed motor milestones
• Recurrent hospital admissions triggered by ordinary childhood infections

In Specific Adult Settings

• Haemodialysis patients: intradialytic hypotension, muscle cramps during sessions, persistent fatigue, and erythropoietin-resistant anaemia have all been linked to low carnitine, though causation is not settled
• People on long-term valproate: fatigue, weakness, raised ammonia, occasionally hepatic injury

None of these symptoms is specific to carnitine. Fatigue and muscle aching have dozens of far commoner causes, and the presence of tiredness alone is not a reason to assume a carnitine problem. What raises genuine suspicion is the pattern: fasting intolerance with low ketones, unexplained cardiomyopathy, recurrent rhabdomyolysis, or symptoms in someone with a known risk factor such as dialysis or valproate therapy.

Who Is at Risk of Carnitine Deficiency?

Genetic

• Two pathogenic variants in SLC22A5 (OCTN2 transporter) — primary systemic carnitine deficiency
• Other inherited fatty-acid oxidation defects (for example medium- and long-chain acyl-CoA dehydrogenase deficiencies)
• Organic acidaemias such as propionic, methylmalonic, glutaric and isovaleric acidaemia, which consume carnitine
• A sibling or parent with a confirmed diagnosis — carrier and family testing is warranted

Kidney-Related

• Long-term maintenance haemodialysis — the most consistently documented adult risk group
• Peritoneal dialysis, to a lesser degree
• Fanconi syndrome and other renal tubular disorders causing carnitine wasting

Medications

• Valproic acid / sodium valproate — the classic drug cause, especially in young children on multiple anticonvulsants
• Pivalate-conjugated antibiotics (pivmecillinam, pivampicillin) — pivalic acid is excreted as pivaloylcarnitine
• Certain antiretrovirals, cisplatin and ifosfamide

Gastrointestinal, Hepatic and Nutritional

• Cirrhosis and advanced liver disease — impaired synthesis
• Short bowel syndrome, severe Crohn's disease, coeliac disease and other malabsorption states
• Long-term carnitine-free parenteral nutrition
• Severe protein-energy malnutrition, anorexia nervosa
• Deficiency of the synthesis cofactors: vitamin C, vitamin B6, niacin or iron

Life Stage and Other

• Preterm and low-birthweight infants — immature synthesis, small stores, high energy turnover
• Pregnancy, where plasma levels fall physiologically; a low newborn screen may in fact reflect maternal deficiency
• Strict long-term vegan or vegetarian diets — lower levels are expected, but clinical deficiency from diet alone is not established in healthy people
• Chronic haemodialysis combined with poor appetite, which stacks two risks

How Is Carnitine Deficiency Tested?

Carnitine status is measured directly in blood, and the interpretation depends as much on the ratio of bound to free carnitine as on the absolute number. Reference ranges vary meaningfully between laboratories and with age, so always read a result against the range printed on your own report rather than a number found online.

Core Tests

• Plasma free carnitine and total carnitine — the primary measurement. Very low free carnitine is the hallmark of primary deficiency.
• Acylcarnitine-to-free-carnitine ratio — a raised ratio points to acyl groups accumulating and suggests a secondary cause such as an organic acidaemia or a fatty-acid oxidation defect, rather than simple depletion.
• Plasma acylcarnitine profile by tandem mass spectrometry — identifies the specific chain lengths that are accumulating and can name the underlying metabolic disorder.
• Urine organic acids — screens for organic acidaemias that consume carnitine.
• Urine carnitine (free and total) with fractional excretion — heavy urinary loss despite a low plasma level is the signature of the OCTN2 transporter defect.

Confirmatory and Specialist Tests

• SLC22A5 gene sequencing — confirms primary carnitine deficiency and allows family testing and carrier detection.
• Carnitine transport study in cultured skin fibroblasts — functional confirmation when genetics are ambiguous.
• Muscle carnitine on biopsy — occasionally used when a myopathic, tissue-limited deficiency is suspected despite normal plasma levels.
• Newborn screening (dried blood spot C0) — a low free carnitine on the heel-prick card is how most primary cases are now found, though a low value can also reflect the mother's undiagnosed deficiency.

Supporting Workup

• Echocardiogram and ECG if cardiomyopathy or arrhythmia is a concern
• Creatine kinase, liver enzymes, ammonia, glucose and ketones — ideally drawn during a symptomatic episode, which is when the abnormalities appear
• Renal function and dialysis adequacy in kidney patients; valproate level and duration in those on the drug

Two practical cautions. First, taking a carnitine supplement before testing will normalise the plasma level and can mask a genuine transporter defect — testing should generally precede supplementation. Second, a modestly low plasma carnitine in an otherwise well adult with no risk factor is common and usually of no clinical consequence; it is not by itself a diagnosis.

How Is Carnitine Deficiency Corrected?

The correct approach depends entirely on which kind of deficiency is present, and the first step is always to find and address the cause rather than simply topping up the tank.

Primary Carnitine Deficiency

This is a prescription-medicine situation. Oral levocarnitine, given in divided doses through the day and continued lifelong, is the standard of care under a metabolic physician, with dosing individualised to plasma levels, growth and cardiac response. Cardiomyopathy and muscle weakness typically improve substantially over weeks to months of consistent treatment, and children identified on newborn screening and treated from the outset generally do well — but this is management of a chronic genetic condition, not a cure, and stopping treatment allows the deficiency to return. Families are also given a written emergency plan for illness, because fasting is the trigger for crises.

Secondary Deficiency: Treat the Driver

• Valproate-associated depletion — discuss dose, alternative anticonvulsants or supplemental carnitine with the prescribing neurologist. Never stop an anticonvulsant independently.
• Haemodialysis — carnitine is removed with each session. Intravenous or oral levocarnitine is used in some units for cramps, intradialytic hypotension or anaemia responsiveness; this belongs to the renal team, and dosing in kidney failure is not the same as in healthy adults.
• Parenteral nutrition, especially in preterm infants — carnitine-free formulations deplete stores within weeks; supplementation is routinely considered.
• Malabsorption, short bowel, cirrhosis, severe undernutrition — nutritional rehabilitation with attention to protein intake and to the vitamin C, B6, niacin and iron that synthesis requires.
• Underlying fatty-acid oxidation or organic acid disorders — carnitine is one part of a specialist regimen, alongside fasting avoidance and specific dietary modification.

Everyday Measures

• Avoid prolonged fasting; regular meals and a bedtime carbohydrate snack are standard advice for anyone with a fat-oxidation problem
• Have a plan for sick days, when appetite drops and energy demand rises — this is when crises happen
• Include red meat, fish, poultry and dairy if your diet allows; ensure adequate protein and the synthesis cofactors if it does not
• Pace endurance exercise and stop at the first sign of muscle pain or dark urine

Forms and Practical Notes

Only the L-isomer is biologically useful; D-carnitine and DL mixtures can interfere with L-carnitine and are not appropriate. Acetyl-L-carnitine and propionyl-L-carnitine are studied for other purposes (cognition, peripheral arterial disease) and are not interchangeable with levocarnitine for treating systemic deficiency. High oral doses are poorly absorbed, so splitting the daily amount across meals is usual. The commonest side effects are nausea, diarrhoea, abdominal cramping and a distinctly fishy body odour from bacterial conversion in the gut. Anyone taking carnitine for a diagnosed deficiency should be monitored with plasma levels rather than treated blind.

Which Foods Supply Carnitine?

Dietary carnitine is concentrated almost entirely in animal muscle tissue — the redder the meat, the higher the content. Absorption from food is efficient (roughly three-quarters of the dose), whereas absorption from high-dose supplements is much poorer, which is one reason dietary sources punch above their weight in ordinary circumstances.

Richest Sources

• Beef and veal — by a wide margin the densest common source, especially cuts from working muscle
• Lamb and mutton
• Venison and other game meats
• Pork

Moderate Sources

• Chicken and turkey, particularly dark meat
• Fish such as cod, haddock and salmon
• Whole milk, cheese and yoghurt
• Liver and other organ meats

Minor Plant and Other Sources

• Tempeh and other fermented soy foods — small amounts
• Avocado — modest
• Asparagus, mushrooms, wheat products, peanut butter — trace quantities

Feeding Your Own Synthesis

Because the body manufactures a substantial share of its carnitine, the raw materials matter as much as pre-formed carnitine for most people. Endogenous synthesis needs:

• Lysine and methionine — from any adequate protein source, animal or plant
• Vitamin C — citrus, peppers, berries, brassicas; classical scurvy fatigue is partly a carnitine synthesis failure
• Vitamin B6 — poultry, fish, potatoes, chickpeas, bananas
• Niacin — meat, fish, peanuts, fortified grains
• Iron — meat, pulses, fortified cereals

A well-planned vegetarian or vegan diet supplies little pre-formed carnitine, and blood levels in long-term plant-based eaters do sit lower than in omnivores. In practice the kidney compensates by reabsorbing more, and clinically meaningful deficiency from diet alone in an otherwise healthy adult is not an established phenomenon. Diet is also not the answer to primary carnitine deficiency: no realistic amount of steak can overcome a broken transporter, and treatment there is pharmacological.

What Happens If Carnitine Deficiency Is Not Addressed?

The consequences of untreated carnitine deficiency are driven by a simple failure: cells that should be burning fat cannot, so during any period of fasting, fever, prolonged exercise or surgery they run out of fuel while circulating fatty acids build up. In primary carnitine deficiency this produces the two serious end-organ patterns. The first is progressive dilated cardiomyopathy, which without treatment can advance to heart failure and life-threatening arrhythmia; it is one of the few cardiomyopathies of childhood that responds well and often dramatically to a specific nutrient replacement, which is precisely why the diagnosis matters. The second is acute metabolic decompensation: hypoketotic hypoglycaemia with lethargy, vomiting, hyperammonaemia and liver dysfunction, which can progress to seizures, coma, brain injury or death if the low blood sugar is not corrected promptly. Deaths in undiagnosed children have been reported during what began as an ordinary viral illness, and this is why newborn screening for the condition exists.

Skeletal muscle complications include chronic proximal weakness and recurrent rhabdomyolysis, which can in turn cause acute kidney injury when large amounts of myoglobin reach the kidneys. In secondary deficiency the picture is usually less dramatic but still consequential: in dialysis patients, persistent low carnitine has been associated with muscle cramps, intradialytic hypotension, poor exercise capacity and anaemia that responds inadequately to erythropoietin; in people on long-term valproate, carnitine depletion is one of the factors implicated in hyperammonaemic encephalopathy and, rarely, in hepatotoxicity. In preterm infants on carnitine-free intravenous nutrition, stores fall quickly and fat utilisation suffers at a time of intense growth.

The encouraging counterpart is that these are largely preventable outcomes. Identified early and treated consistently with prescription levocarnitine, cardiac function in primary deficiency commonly improves markedly, muscle strength recovers, and crises can be headed off with a sick-day plan that prevents fasting. The risk sits overwhelmingly with the undiagnosed and the untreated — and with people who stop treatment because they feel well, since feeling well is the effect of the treatment, not evidence that it is no longer needed.